Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -359.05 Thousand USD | -216.22% |
| 2023 | 308.94 Thousand USD | 120.76% |
| 2022 | 139.94 Thousand USD | -78.77% |
| 2021 | 659.1 Thousand USD | 1.37% |
| 2020 | 650.18 Thousand USD | 183.15% |
| 2019 | 229.62 Thousand USD | 53.47% |
| 2018 | 149.62 Thousand USD | -61.84% |
| 2017 | 392.07 Thousand USD | -55.78% |
| 2016 | 886.57 Thousand USD | 16.28% |
| 2015 | 762.41 Thousand USD | -53.05% |
| 2014 | 1.62 Million USD | 32.01% |
| 2013 | 1.23 Million USD | 100.12% |
| 2012 | -1.05 Billion USD | 36.04% |
| 2011 | -1.65 Billion USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 100.0% |
| 1999 | -316.12 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -92.11 Thousand USD | -1.98% |
| 2024 Q1 | -90.32 Thousand USD | -118.3% |
| 2024 Q4 | -85.83 Thousand USD | 5.58% |
| 2024 FY | -359.05 Thousand USD | -216.22% |
| 2024 Q3 | -90.9 Thousand USD | 1.31% |
| 2023 Q3 | -91.87 Thousand USD | -68.87% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | -54.4 Thousand USD | 0.0% |
| 2023 FY | 308.94 Thousand USD | 120.76% |
| 2023 Q4 | 493.68 Thousand USD | 637.32% |
| 2022 FY | 139.94 Thousand USD | -78.77% |
| 2022 Q1 | 131.96 Thousand USD | 285.49% |
| 2022 Q2 | 131.96 Thousand USD | 0.0% |
| 2022 Q4 | 13.11 Thousand USD | -23.37% |
| 2022 Q3 | 17.11 Thousand USD | -87.03% |
| 2021 FY | 659.1 Thousand USD | 1.37% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q4 | 34.23 Thousand USD | -94.52% |
| 2021 Q3 | 624.87 Thousand USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 206.72 Thousand USD | -50.0% |
| 2020 Q1 | 30 Thousand USD | -62.5% |
| 2020 FY | 650.18 Thousand USD | 183.15% |
| 2020 Q2 | - USD | -100.0% |
| 2020 Q3 | 413.45 Thousand USD | 0.0% |
| 2019 Q1 | 149.62 Thousand USD | 100.0% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | 80 Thousand USD | 0.0% |
| 2019 FY | 229.62 Thousand USD | 53.47% |
| 2018 FY | 149.62 Thousand USD | -61.84% |
| 2018 Q3 | 74.81 Thousand USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 74.81 Thousand USD | -0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | 392.07 Thousand USD | -55.78% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q2 | 387.43 Thousand USD | 8258.96% |
| 2017 Q1 | 4635.00 USD | -97.74% |
| 2016 FY | 886.57 Thousand USD | 16.28% |
| 2016 Q3 | 301.03 Thousand USD | 59.81% |
| 2016 Q2 | 188.36 Thousand USD | -2.15% |
| 2016 Q4 | 204.66 Thousand USD | -32.01% |
| 2016 Q1 | 192.5 Thousand USD | -3.07% |
| 2015 Q4 | 198.61 Thousand USD | 494.04% |
| 2015 FY | 762.41 Thousand USD | -53.05% |
| 2015 Q1 | 51.29 Thousand USD | -92.74% |
| 2015 Q2 | 479.07 Thousand USD | 833.94% |
| 2015 Q3 | 33.43 Thousand USD | -93.02% |
| 2014 Q1 | 195.59 Thousand USD | -51.63% |
| 2014 Q2 | 644.88 Thousand USD | 229.7% |
| 2014 Q3 | 76.31 Thousand USD | -88.17% |
| 2014 Q4 | 706.97 Thousand USD | 826.41% |
| 2014 FY | 1.62 Million USD | 32.01% |
| 2013 Q4 | 404.36 Thousand USD | 93.68% |
| 2013 FY | 1.23 Million USD | 100.12% |
| 2013 Q1 | -553.87 Million USD | 47.69% |
| 2013 Q2 | 400.11 Thousand USD | 100.07% |
| 2013 Q3 | 208.78 Thousand USD | -47.82% |
| 2012 FY | -1.05 Billion USD | 36.04% |
| 2012 Q2 | - USD | 100.0% |
| 2012 Q1 | -549.93 Thousand USD | 97.67% |
| 2012 Q3 | 958.07 Thousand USD | 0.0% |
| 2012 Q4 | -1.05 Billion USD | -110616.77% |
| 2011 Q4 | -23.6 Million USD | -4314.61% |
| 2011 Q1 | -882.6 Thousand USD | 0.0% |
| 2011 FY | -1.65 Billion USD | 0.0% |
| 2011 Q2 | -933.47 Thousand USD | -5.76% |
| 2011 Q3 | -534.74 Thousand USD | 42.71% |
| 2010 Q3 | -429.5 Thousand USD | 0.0% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 100.0% |
| 2002 Q3 | -14.5 Thousand USD | 18.16% |
| 2002 Q2 | -17.72 Thousand USD | 14.07% |
| 2002 Q1 | -20.62 Thousand USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 100.0% |
| 1999 FY | -316.12 Thousand USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 114.081% |
| BrainsWay Ltd. | 23.09 Million USD | 101.555% |
| Cerus Corporation | 86.4 Million USD | 100.416% |
| Envoy Medical, Inc. | -473 Thousand USD | 24.089% |
| electroCore, Inc. | 13.22 Million USD | 102.715% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | 688.618% |
| IceCure Medical Ltd | 1.3 Million USD | 127.62% |
| Inogen, Inc. | 126.69 Million USD | 100.283% |
| OrthoPediatrics Corp. | 111.25 Million USD | 100.323% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 94.065% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | -658.528% |
| MaxCyte, Inc. | 36.54 Million USD | 100.982% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 178.651% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 522.122% |
| Orthofix Medical Inc. | 486.27 Million USD | 100.074% |
| PAVmed Inc | -3.96 Million USD | 90.951% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 93.454% |
| RxSight, Inc. | 53.76 Million USD | 100.668% |
| Sight Sciences, Inc. | 69.17 Million USD | 100.519% |
| SI-BONE, Inc. | 109.42 Million USD | 100.328% |
| TELA Bio, Inc. | 40.11 Million USD | 100.895% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 100.236% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 104.341% |
| Acutus Medical, Inc. | -3.13 Million USD | 88.554% |
| Talis Biomedical Corporation | 371 Thousand USD | 196.781% |
| Spectral AI, Inc. | 7.88 Million USD | 104.557% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 94.553% |
| CVRx, Inc. | 33.03 Million USD | 101.087% |
| DIH Holding US, Inc. Warrants | - USD | Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 148.552% |
| Bioventus Inc. | 328.19 Million USD | 100.109% |
| Venus Concept Inc. | 52.16 Million USD | 100.688% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 102.257% |
| LivaNova PLC | 771.25 Million USD | 100.047% |
| 908 Devices Inc. | 25.32 Million USD | 101.418% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 100.116% |
| Nemaura Medical Inc. | -1.47 Million USD | 75.68% |
| NeuroPace, Inc. | 48.12 Million USD | 100.746% |
| LENSAR, Inc. | 21.1 Million USD | 101.701% |
| Apyx Medical Corporation | 14.12 Million USD | 102.543% |
| Cutera, Inc. | 41.49 Million USD | 100.865% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 101.945% |
| BioSig Technologies, Inc. | 18 Thousand USD | 2094.761% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 100.348% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 102.637% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 100.04% |
| Axonics, Inc. | 274.55 Million USD | 100.131% |
| Outset Medical, Inc. | 29 Million USD | 101.238% |
| IRIDEX Corporation | 21.8 Million USD | 101.647% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 100.505% |
| IRadimed Corporation | 50.15 Million USD | 100.716% |
| Tivic Health Systems, Inc. | 287 Thousand USD | 225.107% |
| INVO Bioscience, Inc. | 1.08 Million USD | 133.058% |
| Telesis Bio, Inc. | 16.95 Million USD | 102.118% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 100.318% |
| Varex Imaging Corporation | 256.9 Million USD | 100.14% |
| Quipt Home Medical Corp. | 163.84 Million USD | 100.219% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 11.562% |
| Pulmonx Corporation | 50.75 Million USD | 100.707% |
| Dynatronics Corporation | 7.63 Million USD | 104.703% |
| Modular Medical, Inc. | -768 Thousand USD | 53.248% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 106.472% |
| Semler Scientific, Inc. | 61.2 Million USD | 100.587% |
| InMode Ltd. | 411.34 Million USD | 100.087% |
| Bruker Corporation | 1.51 Billion USD | 100.024% |
| Cytosorbents Corporation | 22.39 Million USD | 101.604% |
| DexCom, Inc. | 2.28 Billion USD | 100.016% |
| Align Technology, Inc. | 2.71 Billion USD | 100.013% |
| Viveve Medical, Inc. | 620 Thousand USD | 157.912% |
| ZimVie Inc. | 290.38 Million USD | 100.124% |
| Movano Inc. | -158 Thousand USD | -127.251% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 100.328% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 522.122% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 100.098% |
| Profound Medical Corp. | 4.51 Million USD | 107.954% |
| Insulet Corporation | 1.15 Billion USD | 100.031% |
| enVVeno Medical Corporation | -546 Thousand USD | 34.239% |
| Surmodics, Inc. | 93.05 Million USD | 100.386% |
| iCAD, Inc. | 14.53 Million USD | 102.47% |
| Nuwellis, Inc. | 4.98 Million USD | 107.206% |
| Biotricity, Inc. | 8.35 Million USD | 104.297% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 100.108% |
| InspireMD, Inc. | 1.8 Million USD | 119.87% |
| PAVmed Inc. | -3.96 Million USD | 90.951% |
| BIOLASE, Inc. | 16.72 Million USD | 102.147% |
| Beyond Air, Inc. | -1.3 Million USD | 72.528% |
| FONAR Corporation | 45.14 Million USD | 100.795% |
| AxoGen, Inc. | 127.87 Million USD | 100.281% |
| Vivani Medical, Inc. | -357 Thousand USD | -0.576% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 100.184% |
| Inari Medical, Inc. | 434.56 Million USD | 100.083% |
| UFP Technologies, Inc. | 112.22 Million USD | 100.32% |
| QT Imaging Holdings, Inc. | - USD | Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | 2968.096% |
| Tenon Medical, Inc. | 1.24 Million USD | 128.933% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | -343.28% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 113.667% |
| AdaptHealth Corp. | 479.56 Million USD | 100.075% |
| Sintx Technologies, Inc. | 1.84 Million USD | 119.482% |
| NanoVibronix, Inc. | 1.53 Million USD | 123.361% |
| Quanterix Corporation | 70.64 Million USD | 100.508% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 11.562% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 102.554% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 100.68% |
| TransMedics Group, Inc. | 154.09 Million USD | 100.233% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 108.063% |
| NeuroMetrix, Inc. | 3.94 Million USD | 109.096% |
| Hyperfine, Inc. | 4.75 Million USD | 107.548% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 100.336% |
| Biomerica, Inc. | 611 Thousand USD | 158.765% |
| Bone Biologics Corporation | - USD | Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 100.861% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 54.023% |
| Silk Road Medical, Inc | 127.08 Million USD | 100.283% |